Literature DB >> 22213481

Concise review: Induced pluripotent stem cells versus embryonic stem cells: close enough or yet too far apart?

Josipa Bilic1, Juan Carlos Izpisua Belmonte.   

Abstract

The state of a cell is defined by the genes it transcribes and the epigenetic landscape that regulates their expression. Pluripotent cells have markedly different epigenetic signatures when compared with differentiated cells. Permissive chromatin, high occurrence of bivalent domains, and low levels of heterochromatin allow pluripotent cells to react to distinctive stimuli and undergo changes of cell state by differentiating into various tissues. Differentiated cells can be reprogrammed by a set of transcription factors to induced pluripotent stem cells (iPSC) that convert their transcriptional and epigenetic state to pluripotency and thus closely resemble embryonic stem cells (ESC). However, questions remain on whether the epigenetic reprogramming is complete or if there are some recurring iPSC specific aberrations that impede their full pluripotency potential. For this reason, iPSC need to be closely compared with ESC, which is used as a golden standard for in vitro pluripotency. Transcribed genes, epigenetic landscape, differentiation potential, and mutational load show small but distinctive dissimilarities between these two cell types.
Copyright © 2011 AlphaMed Press.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22213481     DOI: 10.1002/stem.700

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  90 in total

1.  Continuous passages accelerate the reprogramming of mouse induced pluripotent stem cells.

Authors:  Zhi-yan Shan; Yan-shuang Wu; Xue Li; Xing-hui Shen; Zhen-dong Wang; Zhong-hua Liu; Jing-ling Shen; Lei Lei
Journal:  Cell Reprogram       Date:  2014-01-04       Impact factor: 1.987

2.  In search of a surrogate: engineering human beta cell lines for therapy.

Authors:  Brittney N Newby; Naohiro Terada; Clayton E Mathews
Journal:  Trends Endocrinol Metab       Date:  2014-06-20       Impact factor: 12.015

3.  Putative immunogenicity expression profiling using human pluripotent stem cells and derivatives.

Authors:  Jason P Awe; Eric H Gschweng; Agustin Vega-Crespo; Jon Voutila; Mary H Williamson; Brian Truong; Donald B Kohn; Noriyuki Kasahara; James A Byrne
Journal:  Stem Cells Transl Med       Date:  2015-01-09       Impact factor: 6.940

Review 4.  Application of biomaterials to advance induced pluripotent stem cell research and therapy.

Authors:  Zhixiang Tong; Aniruddh Solanki; Allison Hamilos; Oren Levy; Kendall Wen; Xiaolei Yin; Jeffrey M Karp
Journal:  EMBO J       Date:  2015-03-12       Impact factor: 11.598

5.  Pluripotent stem cells to hepatocytes, the journey so far.

Authors:  Anwar A Palakkan; Jyoti Nanda; James A Ross
Journal:  Biomed Rep       Date:  2017-03-01

6.  Gene editing and the health of future generations.

Authors:  Christopher Gyngell
Journal:  J R Soc Med       Date:  2017-04-26       Impact factor: 5.344

7.  In Vitro Differentiation of Human Neural Progenitor Cells Into Striatal GABAergic Neurons.

Authors:  Lin Lin; Juan Yuan; Bjoern Sander; Monika M Golas
Journal:  Stem Cells Transl Med       Date:  2015-05-13       Impact factor: 6.940

Review 8.  Lineage conversion methodologies meet the reprogramming toolbox.

Authors:  Ignacio Sancho-Martinez; Sung Hee Baek; Juan Carlos Izpisua Belmonte
Journal:  Nat Cell Biol       Date:  2012-09       Impact factor: 28.824

9.  hVGAT-mCherry: A novel molecular tool for analysis of GABAergic neurons derived from human pluripotent stem cells.

Authors:  Brooke A DeRosa; Kinsley C Belle; Blake J Thomas; Holly N Cukier; Margaret A Pericak-Vance; Jeffery M Vance; Derek M Dykxhoorn
Journal:  Mol Cell Neurosci       Date:  2015-08-16       Impact factor: 4.314

10.  Therapeutic transdifferentiation: a novel approach for vascular disease.

Authors:  John P Cooke
Journal:  Circ Res       Date:  2013-03-01       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.